Evidence of a Prion-Like Transmission of p53 Amyloid in Saccharomyces cerevisiae

REFERENCES

• Dawson R, Muller L, Dehner A, Klein C, Kessler H, Buchner J. 2003. The N-terminal domain of p53 is natively unfolded. J Mol Biol 332:1131–1141. https://doi.org/10.1016/j.jmb.2003.08.008.
   PubMed Web of Science ®Google Scholar
• Oren M. 1999. Regulation of the p53 tumor suppressor protein. J Biol Chem 274:36031–36034. https://doi.org/10.1074/jbc.274.51.36031.
   PubMed Web of Science ®Google Scholar
• Morales R, Green KM, Soto C. 2009. Cross currents in protein misfolding disorders: interactions and therapy. CNS Neurol Disord Drug Targets 8:363–371. https://doi.org/10.2174/187152709789541998.
   PubMed Web of Science ®Google Scholar
• Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. 1998. Diffusible, nonfibrillar ligands derived from Aβ(1-42) are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95:6448–6453. https://doi.org/10.1073/pnas.95.11.6448.
   PubMed Web of Science ®Google Scholar
• Watts JC, Balachandran A, Westaway D. 2006. The expanding universe of prion diseases. PLoS Pathog 2:e26. https://doi.org/10.1371/journal.ppat.0020026.
   PubMed Web of Science ®Google Scholar
• Harris DA, True HL. 2006. New insights into prion structure and toxicity. Neuron 50:353–357. https://doi.org/10.1016/j.neuron.2006.04.020.
   PubMed Web of Science ®Google Scholar
• Coustou V, Deleu C, Saupe S, Begueret J. 1997. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci U S A 94:9773–9778. https://doi.org/10.1073/pnas.94.18.9773.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. 2004. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 6:1054–1061. https://doi.org/10.1038/ncb1104-1054.
   PubMed Web of Science ®Google Scholar
• Muller PAJ, Vousden KH, Norman JC. 2011. p53 and its mutants in tumor cell migration and invasion. J Cell Biol 192:209–218. https://doi.org/10.1083/jcb.201009059.
   PubMed Web of Science ®Google Scholar
• Ano Bom APD, Rangel LP, Costa DCF, de Oliveira GAP, Sanches D, Braga CA, Gava LM, Ramos CHI, Cepeda AOT, Stumbo AC, De Moura Gallo CV, Cordeiro Y, Silva JL. 2012. Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer. J Biol Chem 287:28152–28162. https://doi.org/10.1074/jbc.M112.340638.
   PubMed Web of Science ®Google Scholar
• Kraiss S, Lorenz A, Montenarh M. 1992. Protein-protein interactions in high molecular weight forms of the transformation-related phosphoprotein p53. Biochim Biophys Acta 1119:11–18. https://doi.org/10.1016/0167-4838(92)90227-5.
   PubMedGoogle Scholar
• Forget KJ, Tremblay G, Roucou X. 2013. p53 aggregates penetrate cells and induce the co-aggregation of intracellular p53. PLoS One 8:e69242. https://doi.org/10.1371/journal.pone.0069242.
   PubMed Web of Science ®Google Scholar
• Silva JL, Gallo CVDM, Costa DCF, Rangel LP. 2014. Prion-like aggregation of mutant p53 in cancer. Trends Biochem Sci 39:260–267. https://doi.org/10.1016/j.tibs.2014.04.001.
   PubMed Web of Science ®Google Scholar
• Aguzzi A. 2009. Cell biology: beyond the prion principle. Nature 459:924–925. https://doi.org/10.1038/459924a.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Ghosh D, Ranganathan S, Anoop A, Kumar SP, Jha NN, Padinhateeri R, Maji SK. 2014. Investigating the intrinsic aggregation potential of evolutionarily conserved segments in p53. Biochemistry 53:5995–6010. https://doi.org/10.1021/bi500825d.
   PubMedGoogle Scholar
• Scharer E, Iggo R. 1992. Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res 20:1539–1545. https://doi.org/10.1093/nar/20.7.1539.
   PubMedGoogle Scholar
• Abdelmoula-Souissi S, Delahodde A, Bolotin-Fukuhara M, Gargouri A, Mokdad-Gargouri R. 2011. Cellular localization of human p53 expressed in the yeast Saccharomyces cerevisiae: effect of NLSI deletion. Apoptosis 16:746–756. https://doi.org/10.1007/s10495-011-0607-z.
   PubMedGoogle Scholar
• Xue W-F, Homans SW, Radford SE. 2008. Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc Natl Acad Sci U S A 105:8926–8931. https://doi.org/10.1073/pnas.0711664105.
   PubMed Web of Science ®Google Scholar
• Collins SR, Douglass A, Vale RD, Weissman JS. 2004. Mechanism of prion propagation: amyloid growth occurs by monomer aDdition. PLoS Biol 2:e321. https://doi.org/10.1371/journal.pbio.0020321.
   PubMed Web of Science ®Google Scholar
• Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, Necula M, Margol L, Wu J, Breydo L, Thompson JL, Rasool S, Gurlo T, Butler P, Glabe CG. 2007. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener 2:18. https://doi.org/10.1186/1750-1326-2-18.
   PubMed Web of Science ®Google Scholar
• Hadj Amor IY, Smaoui K, Chaabene I, Mabrouk I, Djemal L, Elleuch H, Allouche M, Mokdad-Gargouri R, Gargouri A. 2008. Human p53 induces cell death and downregulates thioredoxin expression in Saccharomyces cerevisiae. FEMS Yeast Res 8:1254–1262. https://doi.org/10.1111/j.1567-1364.2008.00445.x.
   PubMedGoogle Scholar
• Selivanova G, Ryabchenko L, Jansson E, Iotsova V, Wiman KG. 1999. Reactivation of Mutant p53 through interaction of a C-terminal peptide with the core domain. Mol Cell Biol 19:3395–3402. https://doi.org/10.1128/MCB.19.5.3395.
   PubMed Web of Science ®Google Scholar
• Alberti S, Halfmann R, Lindquist S. 2010. Biochemical, cell biological, and genetic assays to analyze amyloid and prion aggregation in yeast. Methods Enzymol 470:709–734. https://doi.org/10.1016/S0076-6879(10)70030-6.
   PubMedGoogle Scholar
• Hofmann JP, Denner P, Nussbaum-Krammer C, Kuhn P-H, Suhre MH, Scheibel T, Lichtenthaler SF, Schatzl HM, Bano D, Vorberg IM. 2013. Cell-to-cell propagation of infectious cytosolic protein aggregates. Proc Natl Acad Sci U S A 110:5951–5956. https://doi.org/10.1073/pnas.1217321110.
   PubMed Web of Science ®Google Scholar
• Sondheimer N, Lindquist S. 2000. Rnq1: an epigenetic modifier of protein function in yeast. Mol Cell 5:163–172. https://doi.org/10.1016/S1097-2765(00)80412-8.
   PubMed Web of Science ®Google Scholar
• Li L, Kowal AS. 2012. Environmental regulation of prions in yeast. PLoS Pathog 8:e1002973. https://doi.org/10.1371/journal.ppat.1002973.
   Google Scholar
• Edskes HK, Khamar HJ, Winchester C-L, Greenler AJ, Zhou A, McGlinchey RP, Gorkovskiy A, Wickner RB. 2014. Sporadic distribution of prion-forming ability of Sup35p from yeasts and fungi. Genetics 198:605–616.
   PubMedGoogle Scholar
• Park Y-N, Zhao X, Yim Y-I, Todor H, Ellerbrock R, Reidy M, Eisenberg E, Masison DC, Greene LE. 2014. Hsp104 overexpression cures Saccharomyces cerevisiae [PSI+] by causing dissolution of the prion seeds. Eukaryot Cell 13:635–647. https://doi.org/10.1128/EC.00300-13.
   PubMed Web of Science ®Google Scholar
• Ness F, Cox BS, Wongwigkarn J, Naeimi WR, Tuite MF. 2017. Over-expression of the molecular chaperone Hsp104 in Saccharomyces cerevisiae results in the malpartition of [PSI+] propagons. Mol Microbiol 104:125–143. https://doi.org/10.1111/mmi.13617.
   PubMedGoogle Scholar
• Ness F, Ferreira P, Cox BS, Tuite MF. 2002. Guanidine hydrochloride inhibits the generation of prion “seeds” but not prion protein aggregation in yeast. Mol Cell Biol 22:5593–5605. https://doi.org/10.1128/MCB.22.15.5593-5605.2002.
   PubMed Web of Science ®Google Scholar
• Eaglestone SS, Ruddock LW, Cox BS, Tuite MF. 2000. Guanidine hydrochloride blocks a critical step in the propagation of the prion-like determinant [PSI+] of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 97:240–244. https://doi.org/10.1073/pnas.97.1.240.
   PubMed Web of Science ®Google Scholar
• Byrne LJ, Cox BS, Cole DJ, Ridout MS, Morgan BJT, Tuite MF. 2007. Cell division is essential for elimination of the yeast [PSI+] prion by guanidine hydrochloride. Proc Natl Acad Sci U S A 104:11688–11693. https://doi.org/10.1073/pnas.0701392104.
   PubMed Web of Science ®Google Scholar
• Wegrzyn RD, Bapat K, Newnam GP, Zink AD, Chernoff YO. 2001. Mechanism of prion loss after Hsp104 inactivation in yeast. Mol Cell Biol 21:4656–4669. https://doi.org/10.1128/MCB.21.14.4656-4669.2001.
   PubMed Web of Science ®Google Scholar
• Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW. 1995. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268:880–884. https://doi.org/10.1126/science.7754373.
   PubMed Web of Science ®Google Scholar
• Ross CA, Poirier MA. 2004. Protein aggregation and neurodegenerative disease. Nat Med 10(Suppl):S10–S17. https://doi.org/10.1038/nm1066.
   PubMed Web of Science ®Google Scholar
• Uversky VN. 2010. Mysterious oligomerization of the amyloidogenic proteins. FEBS J 277:2940–2953. https://doi.org/10.1111/j.1742-4658.2010.07721.x.
   PubMed Web of Science ®Google Scholar
• Winklhofer KF, Tatzelt J, Haass C. 2008. The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. EMBO J 27:336–349.
   PubMed Web of Science ®Google Scholar
• Ballatore C, Lee VM-Y, Trojanowski JQ. 2007. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8:663–672.
   PubMed Web of Science ®Google Scholar
• Cobb NJ, Surewicz WK. 2009. Prion diseases and their biochemical mechanisms. Biochemistry 48:2574–2585. https://doi.org/10.1021/bi900108v.
   PubMed Web of Science ®Google Scholar
• Price DL, Borchelt DR, Sisodia SS. 1993. Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses. Proc Natl Acad Sci U S A 90:6381–6384. https://doi.org/10.1073/pnas.90.14.6381.
   PubMed Web of Science ®Google Scholar
• Brundin P, Melki R, Kopito R. 2010. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11:301–307. https://doi.org/10.1038/nrm2873.
   PubMed Web of Science ®Google Scholar
• Ishimaru D, Andrade LR, Teixeira LSP, Quesado PA, Maiolino LM, Lopez PM, Cordeiro Y, Costa LT, Heckl WM, Weissmuller G, Foguel D, Silva JL. 2003. Fibrillar aggregates of the tumor suppressor p53 core domain. Biochemistry 42:9022–9027. https://doi.org/10.1021/bi034218k.
   PubMed Web of Science ®Google Scholar
• Wang G, Fersht AR. 2015. Propagation of aggregated p53: cross-reaction and coaggregation vs. seeding. Proc Natl Acad Sci U S A 112:2443–2448. https://doi.org/10.1073/pnas.1500262112.
   PubMedGoogle Scholar
• Kluth M, Harasimowicz S, Burkhardt L, Grupp K, Krohn A, Prien K, Gjoni J, Hass T, Galal R, Graefen M, Haese A, Simon R, Huhne-Simon J, Koop C, Korbel J, Weischenfeld J, Huland H, Sauter G, Quaas A, Wilczak W, Tsourlakis M-C, Minner S, Schlomm T. 2014. Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer. Int J Cancer 135:1369–1380. https://doi.org/10.1002/ijc.28784.
   PubMed Web of Science ®Google Scholar
• Costa DCF, de Oliveira GAP, Cino EA, Soares IN, Rangel LP, Silva JL. 2016. Aggregation and prion-like properties of misfolded tumor suppressors: is cancer a prion disease? Cold Spring Harb Perspect Biol 8:a023614. https://doi.org/10.1101/cshperspect.a023614.
   PubMedGoogle Scholar
• Pereira C, Bessa C, Soares J, Leão M, Saraiva L. 2012. Contribution of yeast models to neurodegeneration research. J Biomed Biotechnol 2012:941232. https://doi.org/10.1155/2012/941232.
   PubMedGoogle Scholar
• Helsen CW, Glover JR. 2012. Insight into molecular basis of curing of [PSI+] prion by overexpression of 104-kDa heat shock protein (Hsp104). J Biol Chem 287:542–556. https://doi.org/10.1074/jbc.M111.302869.
   PubMedGoogle Scholar
• Winkler J, Tyedmers J, Bukau B, Mogk A. 2012. Hsp70 targets Hsp100 chaperones to substrates for protein disaggregation and prion fragmentation. J Cell Biol 198:387–404. https://doi.org/10.1083/jcb.201201074.
   PubMed Web of Science ®Google Scholar
• Moll UM, LaQuaglia M, Benard J, Riou G. 1995. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci U S A 92:4407–4411. https://doi.org/10.1073/pnas.92.10.4407.
   PubMed Web of Science ®Google Scholar
• Mori N, Delsite R, Natarajan K, Kulawiec M, Bhujwalla ZM, Singh KK. 2004. Loss of p53 function in colon cancer cells results in increased phosphocholine and total choline. Mol Imaging 3:319–323. https://doi.org/10.1162/1535350042973517.
   PubMedGoogle Scholar
• Laurie NA, Donovan SL, Shih C-S, Zhang J, Mills N, Fuller C, Teunisse A, Lam S, Ramos Y, Mohan A, Johnson D, Wilson M, Rodriguez-Galindo C, Quarto M, Francoz S, Mendrysa SM, Guy RK, Marine J-C, Jochemsen AG, Dyer MA. 2006. Inactivation of the p53 pathway in retinoblastoma. Nature 444:61–66. https://doi.org/10.1038/nature05194.
   PubMed Web of Science ®Google Scholar
• Lee S-H, Woo T-G, Lee S-J, Kim J-S, Ha N-C, Park B-J. 2013. Extracellular p53 fragment re-enters K-Ras mutated cells through the caveolin-1 dependent early endosomal system. Oncotarget 4:2523–2531. https://doi.org/10.18632/oncotarget.1550.
   PubMedGoogle Scholar
• Lee S-H, Lee S-J, Jung YS, Xu Y, Kang HS, Ha N-C, Park B-J. 2009. Blocking of p53-snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function. Neoplasia 11:22–31. https://doi.org/10.1593/neo.81006.
   PubMed Web of Science ®Google Scholar
• Janke C, Magiera MM, Rathfelder N, Taxis C, Reber S, Maekawa H, Moreno-Borchart A, Doenges G, Schwob E, Schiebel E, Knop M. 2004. A versatile toolbox for PCR-based tagging of yeast genes: new fluorescent proteins, more markers and promoter substitution cassettes. Yeast 21:947–962. https://doi.org/10.1002/yea.1142.
   PubMed Web of Science ®Google Scholar
• Mehta GD, Agarwal M, Ghosh SK. 2014. Functional characterization of kinetochore protein, Ctf19 in meiosis, I: an implication of differential impact of Ctf19 on the assembly of mitotic and meiotic kinetochores in Saccharomyces cerevisiae. Mol Microbiol 91:1179–1199. https://doi.org/10.1111/mmi.12527.
   PubMed Web of Science ®Google Scholar
• Chomczynski P. 1993. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15:532–534, 536–537.
   PubMed Web of Science ®Google Scholar
• Bradley ME, Edskes HK, Hong JY, Wickner RB, Liebman SW. 2002. Interactions among prions and prion “strains” in yeast. Proc Natl Acad Sci U S A 99(Suppl 4):S16392–S16399.
   PubMed Web of Science ®Google Scholar
• Goldring ES, Grossman LI, Krupnick D, Cryer DR, Marmur J. 1970. The petite mutation in yeast. Loss of mitochondrial deoxyribonucleic acid during induction of petites with ethidium bromide. J Mol Biol 52:323–335.
   PubMed Web of Science ®Google Scholar